Ionis Pharmaceuticals Shares Rise After UBS Upgrade

MT newswire2026/10/15 19:14

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

03:14 PM EDT, 10/15/2026 (MT Newswires) -- Ionis Pharmaceuticals (IONS) shares rose 3.2% on Thursday after UBS upgraded the stock to buy from neutral and raised its price target to $88 per share from $46. Trading volume stood at nearly 1.3 million shares, compared with a daily average of more than 3.3 million. Price: 44.05, Change: +1.35, Percent Change: +3.16

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Citi analysts pointed out that AI is causing severe polarization in the software industry. Microsoft is experiencing strong revenue growth driven by its Copilot advantage, while companies like Adobe are facing budget pressures. After Salesforce's acquisition of Braze, attention should be paid to organic growth. In an environment of high financing costs, economies of scale will be the key to survival.

智通财经•2026/10/21 05:02